BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4013851)

  • 1. [Comparative study between acid phosphatases and bone gammagraphy in cancer of the prostate].
    González Martín M; Lancina Martín A; Chantada Abal V; Lamas Meilán AC; Miguez Codesido M; Serrano Barrientos J
    Actas Urol Esp; 1985; 9(1):83-8. PubMed ID: 4013851
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of bone scanning, histological and biological studies of bone marrow in the staging of prostate cancer].
    Aguirre F; Díaz González R; Leiva O; Mayor J; Borobia V
    Actas Urol Esp; 1981; 5(2):99-104. PubMed ID: 7270287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of prostatic acid phosphatase and its relation to bone gammagraphy in the diagnosis of cancer of the prostate].
    González Alenda FJ; Castro Beiras JM; Martín Curto LM; Avila Blanco C; Crespo Díez A
    Rev Clin Esp; 1983 Oct; 171(1):47-50. PubMed ID: 6658082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Can we do without bone gammagraphy in the staging of prostatic cancer?].
    Morote J; Olona M; Villa J; Reig C; López MA; de Torres JA; Soler A
    Actas Urol Esp; 1992 Jun; 16(6):487-9; discussion 489-90. PubMed ID: 1509919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone scintigraphy and serum phosphatases in the detection and follow-up of bone metastases in prostatic cancer.
    Liewendahl K; Alfthan O; Ikonen T; Ruutu M; Rannikko S
    Scand J Urol Nephrol; 1984; 18(3):181-5. PubMed ID: 6494827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of bone gammagraphy versus tumor markers (PSA/PAP) in monitoring cancer of the prostate].
    Morote J; de Torres JA
    Actas Urol Esp; 1990; 14(4):268-70. PubMed ID: 1702258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor markers in cancer of the prostate].
    Nogueira March JL; Ojea A; Jamardo D; Figueiredo L; Diez E; Pérez Villanueva J
    Actas Urol Esp; 1985; 9(1):79-82. PubMed ID: 4013850
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cyproterone acetate. Its value in the treatment of prostatic cancer. Apropos of 45 cases].
    Tobelem G; Arvis G
    Therapie; 1988 May; 43(3):179-82. PubMed ID: 2971278
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of serum acid phosphatases, conventional x-ray diagnosis, bone biopsy and Sr 85-bone scanning in the diagnosis of osseous metastases in cancer of the prostate].
    Graber P; Rutishauser G; Baumann JM
    Urologe; 1971 Mar; 10(2):60-2. PubMed ID: 5577980
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation and development of the enzyme activity of phosphatases and the gammagraphic distribution of bone deposits in prostatic cancer (preliminary study)].
    Maganto Pavón E; Mateos Torres JA; Verdú Tartajo F; Boronat Tormo F; Mayayo Dehesa T; Romero Aguirre C
    Actas Urol Esp; 1981; 5(2):93-8. PubMed ID: 7270286
    [No Abstract]   [Full Text] [Related]  

  • 11. The bone scan as a monitor of prostatic cancer.
    Stone AR; Merrick MV; Chisholm GD
    Clin Oncol; 1980 Dec; 6(4):349-60. PubMed ID: 7460409
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is it possible to do without bone gammagraphy in the staging of prostatic cancer?].
    Ruiz de la Roja JC; Llorente Abarca C; Romero Cagigal I; Páez Borda A; Fernández González I; Martín Osés E; Berenguer Sánchez A
    Actas Urol Esp; 1995 Feb; 19(2):123-7. PubMed ID: 7539572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on prognosis of prostate cancer with bone metastasis by using pretreatment bone scintigraphy].
    Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Suzuki K
    Hinyokika Kiyo; 1989 Oct; 35(10):1693-9. PubMed ID: 2610178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase in serum with Eiken PAP RIA kit.
    Kida T; Higuchi Y
    Oncology; 1983; 40(5):346-50. PubMed ID: 6621997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of value of routine bone scans in patients with newly diagnosed prostate cancer.
    Gerber G; Chodak GW
    Urology; 1991 May; 37(5):418-22. PubMed ID: 2024388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow aspiration biopsy and bone scanning in the staging of prostatic cancer.
    Varenhorst E; Alund G; Lindström E; Månson JC
    Br J Urol; 1983 Oct; 55(5):534-7. PubMed ID: 6626900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early detection of bone metastases in carcinoma of the prostate using the gamma camera].
    Flores Corral N; Unda M; Jorge A; Arregui R; Prieto N
    Arch Esp Urol; 1985; 38(2):131-6. PubMed ID: 4026394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern developments in the diagnosis and therapy of prostatic cancer].
    Feustel A
    Z Urol Nephrol; 1981 Jul; 74(7):549-52. PubMed ID: 7303979
    [No Abstract]   [Full Text] [Related]  

  • 19. Usefulness of bone marrow serum acid phosphatase in staging carcinoma of the prostate.
    Reynolds RD; Greenberg BR; Martin ND; Lucas RN; Gaffney CN; Hawn L
    Cancer; 1973 Jul; 32(1):181-4. PubMed ID: 4716771
    [No Abstract]   [Full Text] [Related]  

  • 20. MRI or bone scan or both for staging of prostate cancer?
    Venkitaraman R; Sohaib A; Cook G
    J Clin Oncol; 2007 Dec; 25(36):5837-8; author reply 5838-9. PubMed ID: 18089886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.